Home › NDC Lookup › RxCUI directory › RxCUI 800808

Dibasic potassium phosphate 0.26 MG/ML / glucose 50 MG/ML / magnesium chloride 0.00373 MEQ... — RxCUI 800808

RxNorm drug concept · Semantic clinical drug
RxCUI 800808 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI800808
Official nameDibasic potassium phosphate 0.26 MG/ML / glucose 50 MG/ML / magnesium chloride 0.00373 MEQ/ML / potassium chloride 0.00174 MEQ/ML / sodium acetate 0.039 MEQ/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asDibasic K+ phosphate 0.26 MG/ML / Glucose 50 MG/ML / Magnesium Chloride 0.00373 MEQ/ML / K+ Chloride 0.00174 MEQ/ML / Sodium Acetate 0.039 MEQ/ML Injectable Solution; Dibasic Pot phosphate 0.26 MG/ML / Glucose 50 MG/ML / Magnesium Chloride 0.00373 MEQ/ML / Pot Chloride 0.00174 MEQ/ML / Sodium Acetate 0.039 MEQ/ML Injectable Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Potassium Chloride: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats and prevents low potassium. Doctors often use it when you take diuretics or lose fluids through diarrhea or vomiting and food alone isn't enough. The injection is used in...
  • Take tablets and capsules with meals, not on an empty stomach, to protect your stomach. Powders and liquids need to be diluted first. Follow your prescriber's directions and keep y...
  • The most common issue is stomach upset. Taking it with food helps. Call your doctor if you have severe vomiting, belly pain, swelling or bleeding, since that can mean an ulcer or b...
  • Check with me first. Blood pressure medicines such as ACE inhibitors and ARBs, spironolactone, and NSAIDs can raise potassium. Triamterene and amiloride should be avoided with it.
📖 Read our full Potassium Chloride guide →

🕸️ Concept Web — How Dibasic potassium phosphate 0.26 MG/ML / glucose... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dibasic potassium phosphate 0.26 MG/ML / glucose 50 MG/ML / magnesium chloride 0.00373 MEQ/ML / potassium chloride 0.00174 MEQ/ML / sodium acetate 0.039 MEQ/ML Injectable Solution RxCUI 800808

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 6

    The active substance itself — no strength, form, or brand attached yet.

    • Dibasic potassium phosphate 55018
    • Glucose 4850
    • Magnesium chloride 6579
    • Potassium chloride 8591
    • Sodium acetate 56443
    • Dibasic potassium phosphate / glucose / magnesium chloride / potassium chloride / sodium acetate 1007749
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Isolyte P 800809
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dibasic potassium phosphate / glucose / magnesium chloride / potassium chloride / sodium acetate Injectable Solution 800807
    • Dibasic potassium phosphate / glucose / magnesium chloride / potassium chloride / sodium acetate Injectable Product 1155870
    • Dibasic potassium phosphate / glucose / magnesium chloride / potassium chloride / sodium acetate Injectable Solution [Isolyte P] 800811
    • Isolyte P Injectable Product 1166633
    • Injectable Solution 316949
    • Injectable Product 1151126
  4. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 20 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dibasic potassium phosphate 0.26 MG/ML SCDC · 800803
  • Glucose 50 MG/ML SCDC · 315789
  • Magnesium chloride 0.00373 MEQ/ML SCDC · 800804
  • Potassium chloride 0.00174 MEQ/ML SCDC · 800805
  • Sodium acetate 0.039 MEQ/ML SCDC · 800806
  • Dibasic potassium phosphate / glucose / magnesium chloride / potassium chloride / sodium acetate Injectable Solution SCDF · 800807
  • Dibasic potassium phosphate / glucose / magnesium chloride / potassium chloride / sodium acetate Injectable Product SCDG · 1155870

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 800808 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00264-7730-10 24 CONTAINER in 1 CASE (0264-7730-10) / 500 mL in 1 CONTAIN... Isolyte P in Dextrose B. Braun Medical Inc. 1993-06-10
Observed labelers: B. Braun Medical Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.